Others
- JPMA Statement on WTO TRIPS Intellectual Property Waiver
- Three priorities to urgently increase access to COVID-19 vaccines
- Statement by JPMA President on the Passing of Former Prime Minister ABE Shinzo
- Opinion on Access and Benefit Sharing of Digital Sequence Information
- UN Climate Change Conference (COP26): Biopharmaceutical Industry Actions to Tackle Climate Change
- Innovative pharmaceutical industry statement on COP28 Declaration on Climate and Health
- The“JAPANESE CONSENSUS FRAMEWORK FOR ETHICAL COLLABORATION" received the "2023 The Lighthouse Award" for its activities.